7. Sanofi and Happify Health solidify collaboration around prescription DTx designed
to address mental health in people with MS. https://www.sanofi.com/en/media-
room/articles/2019/happify-collaboration.
8. Landi, H. Digital therapeutics company Proteus Digital Health files for Chapter 11
bankruptcy. https://www.fiercehealthcare.com/tech/digital-medicine-company-
proteus-digital-health-files-for-chapter-11-bankruptcy (2020).
9. Amazon Web Services. The Case for Digital Therapeutics. https://www.youtube.
com/watch?v=jqKlsRqpQi0 (2019).
10. Propeller Health | Outcomes. Propeller Health https://www.propellerhealth.com/
outcome/.
11. Chrystyn, H. et al. Real-life inhaler technique in asthma patients using the
electronic ProAir Digihaler. Eur. Respir. J. 54, (2019).
12. etectRx Announces U.S. FDA Clearance of Novel Ingestible Event Marker | etectRx.
https://etectrx.com/etectrx-announces-u-s-fda-clearance-of-novel-ingestible-
event-marker/.
13. Chai, P. R. et al. Oxycodone Ingestion Patterns in Acute Fracture Pain With Digital
Pills. Anesth. Analg. 125, 2105–2112 (2017).
14. Chai, P. R. et al. Short Communication: Bioequivalence of Tenofovir Component of
Tenofovir/Rilpivirine/Emtricitabine in Digital Pills. AIDS Res. Hum. Retroviruses 35,
361–363 (2019).
15. AWS Events. AWS re:Invent 2019: Digital therapeutics and patient personalization
(LFS202). https://www.youtube.com/watch?v=txtbBu-Skwo (2019).
16. Amazon Web Services. Propeller Health Leverages AWS to Help Patients Manage
Respiratory Disease. https://www.youtube.com/watch?v=VYVphIBZ2mU (2020).
17. Barrett, M. et al. AIR Louisville: Addressing Asthma With Technology,
Crowdsourcing, Cross-Sector Collaboration, And Policy. Health Aff. 37, 525–534
(2018).
18. ProAir® DigihalerTM (albuterol sulfate) with companion mobile app. https://www.
proairdigihaler.com/.
19. Propeller Health sensor to be co-packaged with recently approved Enerzair®
Breezhaler® asthma medication in Europe - Propeller Health. Propeller Health
https://www.propellerhealth.com/press/press-release/propeller-health-sensor-to-
be-co-packaged-with-recently-approved-enerzair-breezhaler-asthma-medication-
in-europe/ (2020).
20. Cutanea Life Sciences, Inc. Cutanea Life Sciences Unveils 'Facing ForwardTM,'
New Mobile Application for Acne Patients. PR Newswire https://www.prnewswire.
com/news-releases/cutanea-life-sciences-unveils-facing-forward-new-mobile-
application-for-acne-patients-300495959.html (2017).
21. Knowler, W. C. et al. Reduction in the incidence of type 2 diabetes with lifestyle
intervention or metformin. N. Engl. J. Med. 346, 393–403 (2002).
22. Dutra, L. et al. A meta-analytic review of psychosocial interventions for substance
use disorders. Am. J. Psychiatry 165, 179–187 (2008).
23. Magill, M. & Ray, L. A. Cognitive-behavioral treatment with adult alcohol and illicit
drug users: a meta-analysis of randomized controlled trials. J. Stud. Alcohol Drugs
70, 516–527 (2009).
DIGITAL THERAPEUTICS: HOW CLOUD TECHNOLOGY IS
ENHANCING PATIENT EXPERIENCE AND OUTCOMES
9
OCTOBER
2020
PRESENTED BY: PUBLISHED BY:
